PISANI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 3.938
EU - Europa 3.358
AS - Asia 1.016
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 1
Totale 8.327
Nazione #
US - Stati Uniti d'America 3.929
IE - Irlanda 957
SE - Svezia 741
CN - Cina 516
SG - Singapore 434
IT - Italia 423
UA - Ucraina 392
DE - Germania 319
FI - Finlandia 194
GB - Regno Unito 105
FR - Francia 83
PL - Polonia 38
IN - India 37
BE - Belgio 28
AT - Austria 21
NL - Olanda 20
RU - Federazione Russa 15
IR - Iran 9
CZ - Repubblica Ceca 6
TR - Turchia 6
CA - Canada 5
CH - Svizzera 5
ES - Italia 4
KR - Corea 4
AU - Australia 3
EU - Europa 3
ID - Indonesia 3
JP - Giappone 3
MX - Messico 3
NZ - Nuova Zelanda 3
BR - Brasile 2
CL - Cile 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
LV - Lettonia 1
PH - Filippine 1
Totale 8.327
Città #
Dublin 956
Jacksonville 828
Chandler 699
Singapore 357
Nyköping 321
Beijing 233
Dearborn 193
Princeton 189
Cambridge 179
Ashburn 146
Des Moines 146
Medford 125
Ann Arbor 116
Boardman 98
New York 50
Woodbridge 47
Wilmington 46
Messina 42
San Mateo 40
Shenyang 40
Warsaw 37
Jinan 35
Brussels 27
Nanjing 27
Rome 25
Milan 24
Bremen 22
Pune 22
Houston 21
Seattle 21
Vienna 21
Hebei 20
Los Angeles 20
Munich 20
Tianjin 18
Norwalk 16
Ningbo 15
Zhengzhou 15
Jiaxing 14
Helsinki 13
Lancaster 13
Haikou 12
Naples 12
Fuzhou 11
Hangzhou 11
Ardabil 9
Washington 9
Amsterdam 8
Mumbai 8
Taizhou 8
Nanchang 7
Augusta 6
Catania 6
Hyderabad 6
Taiyuan 6
Auburn Hills 5
Caserta 5
Clearwater 5
Guangzhou 5
Leawood 5
Turin 5
Verona 5
Brno 4
Changsha 4
Faenza 4
Kunming 4
Pozzo Di Gotto 4
Saint Petersburg 4
Bagheria 3
Bari 3
Bronte 3
Herzogenrath 3
Izmir 3
Jakarta 3
Kemerovo 3
Lanzhou 3
London 3
Melito di Napoli 3
Monza 3
Redwood City 3
Riva 3
San Giuliano 3
Stezzano 3
Aachen 2
Acerra 2
Alessandria 2
Atlanta 2
Berlin 2
Cagliari 2
Catanzaro 2
Cedar Knolls 2
Chiampo 2
Chicago 2
Dong Ket 2
Drapia 2
East Los Angeles 2
Edinburgh 2
Elk Grove Village 2
Foggia 2
Forest City 2
Totale 5.554
Nome #
" Stato confusionale di probabile natura iatrogena"; " Verosimile screzio psicotico"; " Sindrome Cefalalgica"; " Disturbo d'Ansia". Varie ipotesi ed una sola diagnosi: SENC 250
Rischio di iperomocisteinemia in pazienti con Epilessia, portatori del diplotipo C677T/A1298C della MTHFR 124
Distribuzione di due polimorfismi genici della MTHFR in pazienti con Epilessia e correlazione con i livelli serici di omocisteina 102
FORCED NORMALISATION: OBSERVATION WITH NEW ANTIEPILEPTIC DRUGS 84
FORCED NORMALISATION: A RETROSPECTIVE ANALYSIS OF RISK FACTORS 74
THE EFFECT OF COMBINING VIGABATRIN AND TIAGABINE, TWO DRUGS WITH COMPLEMENTARY GABAERGIC MECHANISMS, AGAINST NMDA-INDUCED EXCITOTOXICITY 74
ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY 73
beneficial effect of donezepil in a malnourished surgical patient with severe nonalcoholic wernicke's encephalopathy 73
Neuroprotective effects of levetiracetam against kainic acid toxicity are mediated by inhibition of lipid peroxidation 72
Effetto della viloxazina sui livelli ematici di oxcarbazepina e dei relativi metaboliti 72
ATTENTION CHARACTERIZATION IN PATIENTS WITH FRONTAL AND TEMPORAL LOBE EPILEPSY 71
"Valproic acid-amitriptyline interaction in man 70
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 69
Carbamazepine-viloxazine interaction in patients with epilepsy 69
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 68
Aspetti neuropsichiatrici dell'epilessia 67
Normalizzazione forzata e fattori di rischio: un'analisi retrospettiva 67
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study 67
CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION 66
An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis 66
Il concetto di normalizzazione forzata in epilettologia 65
Effect of viloxazine on serum carbamazepine levels in epileptic patients 65
A sensitive gas chromatograpic assay for the determination of serum viloxazine concetration using a nitrogen-phosphorus selective detector". Ther. Drug Monit., 6:484-488, 1984. 65
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. 65
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia 63
Prime esperienze su efficacia e tollerabilità della tiagabina in pazienti con epilessia farmacoresistente 63
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 63
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 62
Ruolo dei farmaci antiepilettici nella neuroprotezione da ischemia cerebrale 62
Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. 61
Is retinal assessment useful in epileptic patients with hyperhomocysteinemia? 61
The effect of lamotrigine on peripheral nerves. 60
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 59
Pharmacokinetics and therapeutic plasma monitoring of antiepileptic drugs 58
Meccanismi eccitotossici in un modello sperimentale in vitro: effetti della lamotrigina sul rilascio di amminoacidi eccitatori 58
Controllo totale di crisi con l’associazione lamotrigina-gabapentin in un caso di epilessia sintomatica. 58
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats 58
INFLUENCE OF COMEDICATION ON THE METABOLISM OF VALPROATE 57
Effects of psychotropic drugs on seizure threshold 57
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide 57
Single-dose kinetics of primidone in acute viral hepatitis 57
Differential interactions of valproic acid and valpromide with Carbamazepine in man 56
Objective cognitive dysfunction assessment in patients with subjective cognitive complaints: does it allow an early differentiation between demnetia and pseudo-dementia? 56
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico 56
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico. 54
Repetitive transcranial magnetic stimulation induced slow wave activity modification: A possible role in disorder of consciousness differential diagnosis? 54
Evaluation of Tricyclic Antidepressant Plasma Levels by an Automated Enzyme Immunoassay (EMIT) in Comparison to a High-Performance Liquid Chromatographic Method 53
EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY 52
Liquid chromatographic assay of lamotrigine,a new antiepileptic drug, by a hig-speed column 52
THE INFLUENCE OF ELECTROENCEPHALOGRAPHIC FOCUS LATERALITY ON EFFICACY OF CARBAMAZEPINE IN COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES 52
ELEVATION OF PLASMA PHENYTOIN BY VILOXAZINE IN EPILEPTIC PATIENTS - A CLINICALLY SIGNIFICANT DRUG-INTERACTION 52
Diurnal fluctuations in plasma drug levels:studies with valproic acid and carbamazepine 52
Differential distribution of epilepsy in patients with different types of dementia: a single-centre, retrospective study 52
Neuroprotective effect of remacemide hydrochloride against NMDA-induced excitotoxicity in isolated chick embryo retina 51
CLINICALLY RELEVANT ANTI-EPILEPTIC DRUG-INTERACTIONS 51
Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment 51
Sodium valproate and valpromide:Differential interactions with carbamazepine in epileptic patients 51
Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities 51
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 51
INTERACTION OF LAMOTRIGINE WITH SODIUM VALPROATE 50
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction 50
VIGABATRIN-INDUCED DECREASE IN SERUM PHENYTOIN CONCENTRATION DOES NOT INVOLVE A CHANGE IN PHENYTOIN BIOAVAILABILITY 49
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study 49
Distribution of attention in normal people as a function of spatial location: Right-left, up-down 49
Attivita' parossistica ed agenti farmacologici: attivazione ed inibizione 49
Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study 49
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 49
Limited place for plasma monitoring of new antiepileptic drugs in clinicalpractice. 48
The 894G > T (Glu298Asp) variant in the endothelial NOSgene and MTHFR polymorphisms influence homocysteine levels in patients withcognitive decline. 48
LAMOTRIGINE IN RESISTANT CHILDHOOD EPILEPSY 47
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients 47
Ipsilesional attentional-approach neglect or crossover effect 47
Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina 47
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration 47
CONTRIBUTION OF INTERICTAL BRAIN PERFUSION SPECT IN ASSESSING PATIENTS WITH EPILEPSY 47
Prevenzione dell’epilettogenesi: revisione della letteratura, raccomandazioni terapeutiche, proposte di ricerca 47
Effects of remacemide and lamotrigine on MNDA-induced excitotoxicity in isolated chick embryo retina 46
The importance of drug interactions in epilepsy therapy 46
Le terapie associative in epilettologia 46
LIQUID-CHROMATOGRAPHIC ANALYSIS OF ANTIEPILEPTIC DRUGS - AN OVERVIEW 46
Identification of amoebae in the CSF in a patient with meningoencephalitis. 46
Valproic acid-ethosuximide interaction: A pharmacokinetic study 46
Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients 46
Increased dipropylacetic acid bioavailability from dipropylacetamide by food 46
Crisi epilettiche indotte dall’assunzione di leflunamide in pazienti in terapia con carbamazepina 46
Clinical and pharmacokinetic study of conventional carbamazepine vs a new controlled-release (CR) formulation: a double-blind, cross-over trial 46
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T polymorphism in Levodopa-treated Parkinson’s disease patients 46
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies 45
Morbidity in patients with epilepsy: type and complications: a European cohort study 45
SOCIAL ASPECTS OF EPILEPSY IN THE ADULT IN SEVEN EUROPEAN COUNTRIES 45
Levetiracetam protects against kainic acid-induced toxicity 45
Il significato del monitoraggio dei farmaci nella compliance 45
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 44
COULD LAMOTRIGINE BE USEFUL IN STATUS EPILEPTICUS - A CASE- REPORT 44
Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine 44
Antiepileptic drug comedications in clinical practice 44
Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis 44
Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy 43
Phenylethylmalonamide in essential tremor.A double-blind controlled study 43
Pharmacokinetics of a valproic acid isomer, valnoctamide, in healthy subjects 43
Totale 5.798
Categoria #
all - tutte 35.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020803 0 0 0 0 0 0 207 143 28 154 247 24
2020/20211.012 149 7 205 56 39 165 16 105 16 101 91 62
2021/20221.118 19 167 23 42 22 3 66 55 25 152 194 350
2022/20232.741 235 172 96 214 257 257 29 182 1.156 17 80 46
2023/2024637 68 122 60 69 46 130 15 26 2 29 8 62
2024/2025579 55 45 89 154 158 75 3 0 0 0 0 0
Totale 8.421